Skip to main content
Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Drug Guidance
  5. Tolvaptan for treating autosomal dominant polycystic kidney disease
Drug guidance

Tolvaptan for treating autosomal dominant polycystic kidney disease

Kidney

4 June 2024

Guidance Recommendations

Back to top